Research Institute
To accelerate the development of reliable treatments for unmet diseases,
NeuroBiogen continues to operate its Corporate R&D Center and
collaborate with Joint research institute which our advisors affiliated.
The role of the Corporate R&D Center

NeuroBiogen Corporate R&D Center is conducting verification of new drug candidates, pharmacological evaluation, and development and verification of effectiveness evaluation to be applied in clinical trials.

  • Target ID
  • Hit ID
  • Lead ID (Target MOA establishment)
  • Clinical trial candidate election
  • Initiate clinical trial
Organization of the Corporate R&D Center
 Verification of new drug candidates
Development of effectiveness evaluation, pharmacological evaluation